What to know
CDC’s Division of Cancer Prevention and Control conducts and supports studies to reduce the burden of cancer and eliminate health disparities.

Overview
CDC contributes data and scientific expertise on:
- Cancer prevention and risk behaviors.
- The quality and appropriate use of cancer screening.
- The cost and cost-effectiveness of cancer control programs.
- Health and wellness after a cancer diagnosis.
- Efforts to advance health equity.
CDC's latest cancer research
- Differences in lung cancer death rates by rural vs. urban status in comparison to all-cancer death rates—United States, 1999–2020
- Eligibility for and reach of the National Breast and Cervical Cancer Early Detection Program, 2018–2021
- Cervical cancer incidence and trends among women aged 15–29 years by county-level economic status and rurality—United States, 2007–2020
- Colorectal cancer messaging and gaps in knowledge among screening-eligible individuals
- Role of community-clinical partnerships to promote cancer screening: lessons learned from the National Breast and Cervical Cancer Early Detection Program
Articles
People who inject drugs have a higher risk of getting liver cancer.
In 2019, about 1.3 million Medicare beneficiaries 65 or older were screened for cervical cancer.
More people with cancer died from another cause during peaks in COVID-19 infection.
Breast cancer deaths are decreasing in the United States overall, but disparities still exist.
Native American people are more likely to get certain cancers compared to non-Hispanic White people.
The HPV vaccine may be helping to reduce cervical cancer.
Millions of pelvic exams and Pap tests done on young women are probably unnecessary.
Less than half of older adults protect their skin from the sun when outside.
Some women who are 65 or older should be screened for cervical cancer.